Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · December 25, 2024

Efficacy of Treatment With Bimekizumab in Patients With Hidradenitis Suppurativa

Archives of Dermatological Research

 

Additional Info

Archives of Dermatological Research
Comparable efficacy of bimekizumab for hidradenitis suppurativa with two- and four-week dosing intervals: a systematic review and meta-analysis
Arch Dermatol Res 2024 Dec 05;317(1)72, S Raja, A Qammar, MH Shuja, A Raja

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading